Tasimelteon
VP-VEC-162-1106
Phase 1 small_molecule completed
Quick answer
Tasimelteon for Renal Impairment is a Phase 1 program (small_molecule) at Vanda Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals Netherlands B.V.
- Indication
- Renal Impairment
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed